CHINA BIOLOGIC PRODS INC's ticker is CBPOXXXX and the CUSIP is 16938C106. A total of 138 filers reported holding CHINA BIOLOGIC PRODS INC in Q2 2016. The put-call ratio across all filers is 1.09 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $535,000 | +133.6% | 4,300 | +115.0% | 0.06% | +75.0% |
| Q1 2016 | $229,000 | +252.3% | 2,000 | +195.4% | 0.03% | +255.6% |
| Q1 2015 | $65,000 | -4.4% | 677 | -32.9% | 0.01% | -10.0% |
| Q4 2014 | $68,000 | +25.9% | 1,009 | +0.9% | 0.01% | +25.0% |
| Q3 2014 | $54,000 | +315.4% | 1,000 | +233.3% | 0.01% | +300.0% |
| Q2 2014 | $13,000 | -85.1% | 300 | -88.1% | 0.00% | -83.3% |
| Q1 2014 | $87,000 | – | 2,516 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SPQ Asia Capital Ltd | 287,277 | $35,760,000 | 28.32% |
| WARBURG PINCUS LLC | 6,674 | $830,780,000 | 13.45% |
| Ariose Capital Management Ltd | 238,841 | $27,689,000 | 7.56% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 12,600 | $1,568,000 | 4.48% |
| RUDMAN ERROL M | 37,001 | $4,606,000 | 3.72% |
| INDUS CAPITAL PARTNERS, LLC | 245,237 | $30,527,000 | 2.89% |
| Ativo Capital Management LLC | 93,784 | $11,674,000 | 2.70% |
| OBERWEIS ASSET MANAGEMENT INC/ | 63,305 | $7,880,000 | 2.27% |
| Point72 Hong Kong Ltd | 31,500 | $3,921,000 | 2.14% |
| Cormorant Asset Management, LP | 112,867 | $14,050,000 | 1.55% |